Cochlear Limited (CHEOY) Research
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.
Market snapshot
- Symbol
- CHEOY
- Price
- $39.98
- Day change
- +3.17%
- Market cap
- $7.7B
- P/E ratio
- 22.38x
- 52-week range
- 31.82-105.6
- Sector
- Healthcare
- Industry
- Medical - Devices
- Analyst price target
- $318.5
Recent news
- Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact
Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast for annual earnings, citing weak trading conditions and uncertainty stoked by the Middle East war.
Peer companies
- Alibaba Health Information Technology Limited (ALBBY)
- Bangkok Dusit Medical Services Public Company Limited (BDUUY)
- CSPC Pharmaceutical Group Limited (CHJTF)
- Eurofins Scientific SE (ERFSF)
- Fisher & Paykel Healthcare Corporation Limited (FSPKF)
- Sonova Holding AG (SONVF)
- Sonova Holding AG (SONVY)
- Sartorius AG (SSSGY)
Open Cochlear Limited (CHEOY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.